Skip to content

Therapeutic effects of herbs on psoriasis

Therapeutic effects of ZAX.1400.P03 on cutaneous clinical manifestations in patients with psoriasis in Fasa city in 1400

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20210218050404N5
Enrollment
104
Registered
2022-03-03
Start date
2022-03-05
Completion date
Unknown
Last updated
2022-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psoriasis. psoriasis vulgaris

Interventions

Intervention 1: Intervention group: ZAX.1400.P03 drug composition, topical and cream-based, twice-daily use for 21 days, and patients are evaluated for up to 42 days. Intervention 2: Control group: Th

Sponsors

Fasa University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Diagnosis of the disease by a doctor Age range between 18 and 60 years Having informed and written consent to participate in the study Tissue involvement only locally and no need to take oral medications

Exclusion criteria

Exclusion criteria: Food and health allergies Existence of underlying diseases and immunodeficienc Incidence of blisters and infections caused by the disease Disagreement of the physician directly responsible for the patient Pregnancy and lactation

Design outcomes

Primary

MeasureTime frame
Extent of lesion. Timepoint: In seven turns; Days zero, 7, 14, 21, 28, 35 and 42. Method of measurement: Relative determination of area with checkered paper.;Redness of the skin. Timepoint: In seven turns; Days zero, 7, 14, 21, 28, 35 and 42. Method of measurement: Visual Analogue Scale checklist.;Swelling of the skin. Timepoint: In seven turns; Days zero, 7, 14, 21, 28, 35 and 42. Method of measurement: Visual Analogue Scale checklist.;Scaling. Timepoint: In seven turns; Days zero, 7, 14, 21, 28, 35 and 42. Method of measurement: Visual Analogue Scale checklist.;Itching. Timepoint: In seven turns; Days zero, 7, 14, 21, 28, 35 and 42. Method of measurement: Visual Analogue Scale checklist.;Skin dryness. Timepoint: In seven turns; Days zero, 7, 14, 21, 28, 35 and 42. Method of measurement: Visual Analogue Scale checklist.;Skin irritation. Timepoint: In seven turns; Days zero, 7, 14, 21, 28, 35 and 42. Method of measurement: Visual Analogue Scale checklist.;Pain. Timepoint: In seven turns; Days zero, 7, 14, 21, 28, 35 and 42. Method of measurement: Visual Analogue Scale checklist.;Skin scratches. Timepoint: In seven turns; Days zero, 7, 14, 21, 28, 35 and 42. Method of measurement: Visual Analogue Scale checklist.;Skin scars. Timepoint: In seven turns; Days zero, 7, 14, 21, 28, 35 and 42. Method of measurement: Visual Analogue Scale checklist.;Skin thickness. Timepoint: In seven turns; Days zero, 7, 14, 21, 28, 35 and 42. Method of measurement: Visual Analogue Scale checklist.;Skin rash. Timepoint: In seven turns; Days zero, 7, 14, 21, 28, 35 and 42. Method of measurement: Visual Analogue Scale checklist.;Recovery time. Timepoint: daily. Method of measurement: By day by checklist.

Secondary

MeasureTime frame
Quality of Life. Timepoint: In seven turns; Days zero, 7, 14, 21, 28, 35 and 42. Method of measurement: DLQI form.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAmin Dakhili Ardestani

Fasa University of Medical Sciences

amindakhiliardestani@yahoo.com0715335907

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026